Back to search

Spain· ES:74631

AMOROLFINA TEVA 50mg/ml BARNIZ DE UÑAS MEDICAMENTOSO

A amorolfine product containing amorolfina, registered in Spain by Teva Pharma S.L.U.. The same ATC class is registered in 15 of our 19 countries.

ATC D01AE16

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedAMOROLFINA TEVA 50mg/ml BARNIZ DE UÑA…ATCD01AE16REGISTER NO.ES:74631PACKS LISTED1CHECKEDAugust 12, 2026

Where it is registered

Amorolfine is registered in 15 of 19 countries.

Countries holding a registration under ATC D01AE16 (amorolfine), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 9 of them publish a price we can compare per daily dose

Amorolfine · ATC D01AE16

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AEMPS CIMA (Spain)
Active substance
amorolfina
Manufacturer
Teva Pharma S.L.U.
Country
Spain (ES)
ATC code
D01AE16
ATC class
Amorolfine
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
August 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    683439
    5
    EUR 21.43

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amorolfine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amorolfine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Amorocutan, Amorolfin Laboratoires Gerda
  • Belgium · Amorolfine Schollmedical, Amorolfine Teva
  • Bulgaria · Екзодерил, Фунгитер
  • Cyprus · Loceryl
  • Czechia · Amorolfin Belupo, Exorolak
  • Germany · Amofin, Amorocutan
  • Denmark · Finail, Loceryl
  • Estonia · Exolorfin, Loceryl
  • Finland · Loceryl
  • France · Amorolfine Arrow, Amorolfine Bgr
  • United Kingdom (Northern Ireland) · Amorolfine Accord-Uk, Amorolfine Aspire Pharma
  • Greece · Loceryl, Schollmed Fungal Nail
  • Croatia · Amofin, Arivil
  • Hungary · Amolak, Amolak Rx
  • Ireland · Amorolfine Bluefish, Amorolfine Rowex
  • Iceland · Amorolfin Alvogen, Amorolfin Apofri
  • Italy · Amorolfina, Amorolfina Mylan Generics
  • Lithuania · Funtrol, Gifugan
  • Luxembourg · Loceryl
  • Latvia · Exolorfin, Loceryl
  • Malta · Loceryl
  • Norway · Loceryl
  • Poland · Amorolak, Funtrol
  • Portugal · Amorolfina Bluefish, Amorolfina Bluepharma
  • Romania · Exoderil Set
  • Sweden · Amorolfin Abece, Amorolfin Apofri
  • Slovenia · Bemofin, Exolorfin
  • Slovakia · Amorolfín Belupo, Exorolfin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6771c833-e81e-4804-a93b-fd28a7406893
GET /v1/drugs/6771c833-e81e-4804-a93b-fd28a7406893?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1326322800000}",
  "nregistro": "74631",
  "substance": "amorolfina"
}

See everything about amorolfine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.